These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 1828396

  • 1. Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.
    Limpens J, Scheper RJ.
    Clin Exp Immunol; 1991 Jun; 84(3):383-8. PubMed ID: 1828396
    [Abstract] [Full Text] [Related]

  • 2. Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.
    Limpens J, Van Meijer M, Van Santen HM, Germeraad WT, Hoeben-Schornagel K, Breel M, Scheper RJ, Kraal G.
    Immunology; 1991 Jul; 73(3):255-63. PubMed ID: 1879874
    [Abstract] [Full Text] [Related]

  • 3. Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
    Gill HK, Liew FY.
    Eur J Immunol; 1978 Mar; 8(3):172-6. PubMed ID: 306925
    [Abstract] [Full Text] [Related]

  • 4. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
    Rondinone SN, Giovanniello OA, Barrios HA, Nota NR.
    J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
    Kawabata TT, White KL.
    Cancer Res; 1988 Jan 01; 48(1):41-5. PubMed ID: 3257162
    [Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide-induced tumour regression of cyclophosphamide-resistant L5178Y lymphoma through suppressor cells elimination.
    Andrade-Mena CE.
    Int J Tissue React; 1994 Jan 01; 16(2):95-103. PubMed ID: 7960506
    [Abstract] [Full Text] [Related]

  • 7. Local administration of various cytostatic drugs after subcutaneous immunization enhances delayed-type hypersensitivity reaction to sheep red blood cells in mice.
    Tan BT, Limpens J, Koken M, Valster H, Scheper RJ.
    Scand J Immunol; 1986 May 01; 23(5):605-9. PubMed ID: 2939555
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon.
    Knop J, Stremmer R, Taborski U, Freitag W, de Maeyer-Guignard J, Macher E.
    J Immunol; 1984 Nov 01; 133(5):2412-6. PubMed ID: 6237149
    [Abstract] [Full Text] [Related]

  • 9. Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.
    Lagrange PH, Michel JC, Hurtrel B, Thickstun PM.
    Ann Immunol (Paris); 1980 Nov 01; 131C(3):257-77. PubMed ID: 7406440
    [Abstract] [Full Text] [Related]

  • 10. Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
    Boerrigter GH, Scheper RJ.
    Clin Exp Immunol; 1984 Oct 01; 58(1):161-6. PubMed ID: 6478648
    [Abstract] [Full Text] [Related]

  • 11. [Development of delayed hypersensitivity to sheep erythrocytes after separate and combined administration of the antigen and cyclophosphamide].
    Chernousov AD, Fontalin LN, Kondrat'eva TK.
    Biull Eksp Biol Med; 1979 May 01; 87(5):449-52. PubMed ID: 313220
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma.
    Livingston PO, Cunningham-Rundles S, Marfleet G, Gnecco C, Wong GY, Schiffman G, Enker WE, Hoffman MK.
    J Biol Response Mod; 1987 Aug 01; 6(4):392-403. PubMed ID: 2957470
    [Abstract] [Full Text] [Related]

  • 13. Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.
    Bovbjerg DH, Ader R, Cohen N.
    Clin Exp Immunol; 1986 Dec 01; 66(3):539-50. PubMed ID: 2436841
    [Abstract] [Full Text] [Related]

  • 14. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
    Takahashi K, Satoh J, Sagara M, Zhu XP, Muto G, Muto Y, Fukuzawa M, Nishimura S, Miyaguchi S, Toyata T.
    J Autoimmun; 1995 Jun 01; 8(3):335-46. PubMed ID: 7575995
    [Abstract] [Full Text] [Related]

  • 15. [Suppressor system of cell-mediated hypersensitivity in the mouse:sheep-erythrocyte model].
    Rondinone SN, Giovanniello OA, Barrios HA, Nota NR.
    Rev Latinoam Microbiol; 1986 Jun 01; 28(3):211-5. PubMed ID: 2954197
    [No Abstract] [Full Text] [Related]

  • 16. Combination therapy of murine tumors with a degraded D-manno-D-glucan (DMG) from Microellobosporia grisea, and cyclophosphamide.
    Nakajima H, Hashimoto S, Kita Y, Takashi T, Tsukada W, Kohno M, Ogawa H, Abe S, Mizuno D.
    Jpn J Exp Med; 1983 Dec 01; 53(6):263-9. PubMed ID: 6240552
    [Abstract] [Full Text] [Related]

  • 17. Activation of type III pneumococcal polysaccharide-specific suppressor T cells in cyclophosphamide-treated mice requirement for recognition of antigen and I-J determinants on antigen coupled to syngeneic spleen cells.
    Braley-Mullen H.
    J Immunol; 1983 Nov 01; 131(5):2190-5. PubMed ID: 6195257
    [Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide-sensitive contrasuppression in TNP-anterior chamber associated immune deviation (TNP-ACAID).
    Waldrep JC, Kaplan HJ.
    J Immunol; 1983 Dec 01; 131(6):2746-50. PubMed ID: 6196397
    [Abstract] [Full Text] [Related]

  • 19. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K, Pellis NR, Kahan BD.
    Cancer Res; 1988 Jan 01; 48(1):101-8. PubMed ID: 3257158
    [Abstract] [Full Text] [Related]

  • 20. Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune responses.
    Diamantstein T, Klos M, Hahn H, Kaufmann SH.
    J Immunol; 1981 May 01; 126(5):1717-9. PubMed ID: 6452475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.